Stay updated on Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial page.

Latest updates to the Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial page
- Check7 days agoChange DetectedAdded a full bibliographic citation for Gupta et al. on enfortumab vedotin plus pembrolizumab in Future Oncology (2026) with volume, pages, DOI, and online publication date, replacing the previous abbreviated online-ahead-of-print reference in the Publications section. This update clarifies the source details for the related patient-reported outcomes study.SummaryDifference0.0%

- Check14 days agoChange DetectedRevision: v3.5.3 replaces v3.5.2. This update reflects a version bump for the page's underlying documentation and tooling.SummaryDifference0.0%

- Check21 days agoChange DetectedUpdated the page revision/version indicator from **v3.5.0** to **v3.5.2**.SummaryDifference0.0%

- Check35 days agoChange DetectedAdded a new publication citation to the Publications section: How enfortumab vedotin plus pembrolizumab affects the quality of life of people with advanced urothelial cancer: Future Oncol (2026).SummaryDifference0.0%

- Check43 days agoChange DetectedAdded a 2026 Pan-Asian subgroup analysis paper on EV-302 and removed the online-ahead-of-print version of the same article from the Publications list.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision indicator updated: added Revision v3.5.0 and removed Revision v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial page.